Sağlık Sitelerinden Haberler


        
 
Bilgi:
Etiketler:
Yazarın adı:
Yazarın soyadı:


EklenmeTarihi: 17 Mart 2022, Perşembe, 00:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24--April 21, 2020
This report describes various factors that contributed to accelerated spread of coronavirus disease 2019 during February--April 2020.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=406737
Etiketler:

EklenmeTarihi: 17 Mart 2022, Perşembe, 00:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Characteristics of Health Care Personnel with COVID-19 --- United States, February 12--April 9, 2020
Improving surveillance through routine reporting of occupation and industry not only benefits health care personnel, but all workers during the coronavirus disease 2019 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=406160
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 22:04
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Misinformation that Omicron is ‘the last COVID-19 variant’ fuelling uptick worldwide: WHO
A combination of factors, including misinformation that the pandemic is over, the lifting of mask mandates, ending physical distancing - and a more transmissible Omicron BA.2 variant - are causing an increase of COVID-19 cases globally, the World Health Organization warned on Wednesday.
https://news.un.org/feed/view/en/story/2022/03/1114062
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 20:03
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020
K. Winglee et al.
https://wwwnc.cdc.gov/eid/article/28/4/21-2014_article
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 12:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022
This report describes COVID-19 hospitalization rates among infants and children aged 0-4 years, including during Omicron variant predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=613117
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 12:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022
This report describes COVID-19 vaccine provider access and vaccination coverage among U.S. children aged 5-11 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=600326
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 12:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022
This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=603187
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 12:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022
This report describes how Omicron infection resulted in high transmission among household contacts. Prevention strategies are important to reduce transmission in households.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=564942
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 12:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575231
Etiketler:

EklenmeTarihi: 16 Mart 2022, Çarşamba, 12:05
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022
This report describes mRNA COVID-19 vaccine effectiveness in preventing emergency department and urgent care encounters as well as hospitalizations among children and adolescents.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575259
Etiketler: